A Beat From Qiagen NV, but Only Half a Raise
It was another solid quarter for Qiagen (NASDAQ: QGEN) as the maker of diagnostic and scientific products continues to post decent revenue growth while getting more efficient, which drives income to grow even faster.
QIAsymphony. Image source: Qiagen.
Metric
Source: Fool.com
Bristol-Myers Squibb Stock
€46.46
11.400%
With 8 Buy predictions and only 2 Sell predictions the community sentiment for the stock is positive.
As a result the target price of 70 € shows a very positive potential of 50.67% compared to the current price of 46.46 € for Bristol-Myers Squibb.
